HPB & Spleen · 7 November 2023

Disparities in Pancreatic Cancer Surgery: Minority Serving Hospitals Face Treatment Challenges

A study exploring the surgical treatment of resectable pancreatic adenocarcinoma in minority serving hospitals (MSH) revealed significant disparities. Patients at MSH were less likely to undergo surgical resection, facing unique barriers, and leading to increased mortality among those who did. These findings highlight the urgent need for targeted interventions to improve the care provided to pancreatic cancer patients at MSH facilities and reduce treatment inequalities.

Journal Article by Olecki EJ, Perez Holguin RA (…) Dixon MEB et 5 al. in J Surg Res

read the whole article in J Surg Res

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Ann Surg Oncol2 Nov 2026

Pancreatic ductoscopy guides tissue preservation

In two older patients having robotic surgery for a pancreatic growth, ductoscopy and checks of the cut edge let surgeons leave the remaining pancreas in place.

HPB & Spleen30 Oct 2026

Intrahepatic cholangiocarcinoma has more options

Resection remains central, but care now includes preoperative therapy, liver-directed treatments and drugs matched to tumor changes.

Ann Surg Oncol29 Oct 2026

Pancreatic cancer: longer survival with combined treatment

For locally advanced pancreatic cancer, cryoablation plus drug treatment was linked to longer median survival than drug treatment alone, but the result does not prove benefit.

All papers in HPB & Spleen →